SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-003770
Filing Date
2020-02-07
Accepted
2020-02-06 19:08:08
Documents
104
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-10q_20191231.htm   iXBRL 10-Q 3584484
2 EX-10.1 mygn-ex101_304.htm EX-10.1 104377
3 EX-31.1 mygn-ex311_305.htm EX-31.1 16764
4 EX-32.1 mygn-ex321_307.htm EX-32.1 6906
  Complete submission text file 0001564590-20-003770.txt   14537252

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mygn-20191231.xsd EX-101.SCH 70595
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20191231_cal.xml EX-101.CAL 93763
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20191231_def.xml EX-101.DEF 252745
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20191231_lab.xml EX-101.LAB 555382
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20191231_pre.xml EX-101.PRE 456682
57 EXTRACTED XBRL INSTANCE DOCUMENT mygn-10q_20191231_htm.xml XML 3637248
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 20584165
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences